Free tool
Drug Trial Radar: Rare and genetic disease
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
6
Not yet recruiting, industry sponsors, Rare and genetic disease, Phase 1
By trial status
The same filters, counted in each status. Pick one to switch.
6 trials
Showing 1 to 6, recently updated first.
- A Study of S-606001 as Monotherapy in Participants With Late-onset Pompe Disease (LOPD)Not yet recruiting
ShionogiIndustry
NCT07787650 · 15 participants (planned) · Start Nov 30, 2026 · Primary completion Oct 31, 2028
Drug: S-606001 · For: Pompe Disease
MipSalus ApsIndustry
NCT07927608 · 7 participants (planned) · Start Nov 2026 · Primary completion Jun 2027
Drug: Phelimin · For: Phenylketonuria (PKU); Phenylketonuria
Sites: Copenhagen, Denmark
- Single Injection of rAAV9-CMV-hNAGLUop Gene for Patients With Mucopolysaccharidosis (MPS) IIIBNot yet recruiting
NeuroGTIndustry
NCT07818759 · 9 participants (planned) · Start Jan 18, 2027 · Primary completion Dec 31, 2028
Drug: rAAV9-CMV-hNAGLUop · For: Sanfilippo Syndrome (MPS III)
Sites: St Louis, Missouri
Gritgen Therapeutics Co., Ltd.Industry
NCT07318909 · 9 participants (planned) · Start Dec 31, 2027 · Primary completion Dec 31, 2028
Drug: GS1168 injection · For: Phenylketonuria (PKU)
Sites: Hefei, China
- A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of VGN-R08b in Patients With Type III Gaucher's DiseaseNot yet recruiting
Shanghai Vitalgen BioPharma Co., Ltd.Industry
NCT07603050 · 12 participants (planned) · Start May 14, 2026 · Primary completion May 29, 2028
Drug: VGN-R08b; VGN-R08b and 1 more · For: Gaucher Disease Type 3
Guangzhou Jiayin Biotech LtdIndustry
NCT06819514 · 16 participants (planned) · Start Mar 1, 2025 · Primary completion Mar 15, 2028
Drug: EXG110 Injection · For: Fabry Disease
Sites: Nanjing, China; Hangzhou, China · 3 sites in all
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.